Enhancing Precision and Safety in the Development of CNS Genetic Medicines

Mind the Methods · Sep 2, 2026 · 32m · transcript

Tune in to ISCTM’s Mind the Methods podcast with Dr. Kemi Olugemo, ISCTM Scientific Committee member and consulting Chief Medical Officer at Junevity, and Dr. Mo Heidaran, NIH-trained scientist and former FDA Division of Cell and Gene Therapy leader. Together, they explore precision and safety in genetic medicines for CNS disorders—from gene-editing platforms and manufacturing quality to patient selection, off-target effects, and long-term safety monitoring. They also discuss how AI can support development while keeping human expertise and accountability central.